AONN+ Statement About COVID-19

Press Releases published on March 13, 2020 in News & Updates, COVID-19

AONN+ Position COVID-19

In light of the COVID-19 novel coronavirus, the Academy of Oncology Nurse & Patient Navigators (AONN+) is aware of the increased acuity of patient care that navigators are managing on a daily basis with patients with cancer and their families. In response, we aim to support our professional members with credible resources/information they can use to educate and empower those around them as well as alleviate fears. The navigator’s primary responsibility to the patient is to follow the mandatory guidelines set by their federal, state, and/or healthcare institution.

Patient Empowerment

Patient empowerment is a key competency skill for all navigators and is reflected in AONN+ knowledge domains as well as the National Navigation Roundtable competency domains. As discussions are held with patients with cancer, their families, and other community members, it is critical to apply insight and understanding about emotions, and human responses to emotions, to create and maintain positive interpersonal interactions. Please demonstrate interpersonal and communication skills that result in the effective exchange of information and collaboration across the broad range of socioeconomic and cultural backgrounds encountered daily.

A Message From AONN+ Program Director Sharon Gentry

A message from our Program Director Sharon Gentry to the AONN+ community and all the healthcare workers working tirelessly to save lives during the COVID-19 outbreak.

View Our COVID-19 Navigator Toolkit Read FAQs on CONQUER

Related Items
Colorectal Cancer Screening Update: with Andi Dwyer, MPH
News & Updates published on June 23, 2026 in News & Updates
In this interview, AONN+ Board of Trustees member Andi Dwyer discusses the American Cancer Society’s updated colorectal cancer screening guidelines, including new stool-based tests and the first-ever recommendation of an FDA-approved blood-based screening test, while emphasizing that colonoscopy and stool tests remain the most effective tools for early detection and prevention.
AONN+ Joins Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026
News & Updates published on June 23, 2026 in News & Updates
Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026 brought together advocacy leaders, including AONN+ Executive Director Candice Roth, MSN, RN, CENP, to discuss emerging cancer therapies, the role of artificial intelligence in patient-centered care, and the launch of Pfizer’s new Patient Advocacy360 partnership framework.
AONN+ Takes Part in CAR T Vision Coalition Event
News & Updates published on June 23, 2026 in News & Updates
Candice Roth, MSN, RN, CENP, and Monica Dean represented AONN+ at the launch of the first U.S. CAR T Vision to Action Blueprint, a stakeholder-driven initiative that provides practical strategies and tools to address access barriers and expand the use of CAR T-cell therapy for eligible patients nationwide by 2030.